Your browser doesn't support javascript.
loading
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Welén, Karin; Överby, Anna K; Ahlm, Clas; Freyhult, Eva; Robinsson, David; Henningsson, Anna Jonsson; Stranne, Johan; Bremell, Daniel; Angelin, Martin; Lindquist, Elisabeth; Buckland, Robert; Carlsson, Camilla Thellenberg; Pauksens, Karlis; Bill-Axelsson, Anna; Akre, Olof; Ryden, Cecilia; Wagenius, Magnus; Bjartell, Anders; Nilsson, Anna C; Styrke, Johan; Repo, Johanna; Balkhed, Åse Östholm; Niward, Katarina; Gisslén, Magnus; Josefsson, Andreas.
Affiliation
  • Welén K; Department of Urology/Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30, Gothenburg, Sweden. karin.welen@gu.se.
  • Överby AK; Department of Clinical Microbiology, Section of Virology, Umeå University, Umeå, Sweden.
  • Ahlm C; Molecular Infection Medicine Sweden, Umeå University, Umeå, Sweden.
  • Freyhult E; Department of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.
  • Robinsson D; Department of Medical Sciences, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Henningsson AJ; Department of Urology, Region of Jönköping, Jönköping, Sweden.
  • Stranne J; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Bremell D; Department of Clinical Microbiology, Region Jönköping County, Jönköping, Sweden.
  • Angelin M; Department of Urology/Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30, Gothenburg, Sweden.
  • Lindquist E; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Buckland R; Department of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.
  • Carlsson CT; Department of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.
  • Pauksens K; Department of Surgical and Perioperative Sciences, Urology & Andrology, Umeå University, 901 87, Umeå, Sweden.
  • Bill-Axelsson A; Wallenberg Center for Molecular Medicine, Umeå University, Umeå, Sweden.
  • Akre O; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Ryden C; Department of Infectious Diseases, Uppsala University Hospital, Uppsala, Sweden.
  • Wagenius M; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Bjartell A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Nilsson AC; Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Styrke J; Division of Urological Cancers, Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Repo J; Division of Urological Cancers, Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Balkhed ÅÖ; Department of Translational Medicine, Infectious Diseases Research Unit, Lund University, Malmö, Sweden.
  • Niward K; Department of Surgical and Perioperative Sciences, Urology & Andrology, Umeå University, 901 87, Umeå, Sweden.
  • Gisslén M; Department of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.
  • Josefsson A; Department of Clinical Microbiology, Region Jönköping County, Jönköping, Sweden.
Trials ; 22(1): 209, 2021 Mar 16.
Article in En | MEDLINE | ID: mdl-33726804
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Phenylthiohydantoin / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2021 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Phenylthiohydantoin / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2021 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido